VIENNALAB - Established innovations in diagnostics

Highly active retroviral therapy (HAART) is a very effective treatment for HIV-positive patients. Allelic variants of certain proteins are known to be associated with success of HAART. The PGX-HIV StripAssay® identifies mutations in genes known to be relevant for the success of HAART.

Highly active retroviral therapy (HAART) is a very effective treatment for HIV-positive patients. Allelic variants of certain proteins are known to be associated with success of HAART.

The PGX-HIV StripAssay® identifies mutations in genes known to be relevant for the success of HAART.

Response to HAART Therapy

  • HAART has brought substantial improvements to HIV-positive patients and has led to a large reduction in AIDS-related mortality in countries where it became available.
  • Allelic variants of the multidrug transporter P-glycoprotein 1 (MDR1), cytochrome P450 isozyme 2D6, and the C-C chemokine receptor 5 are known to be associated with success of this therapy.
  • Identification of relevant genetic variations allows better guidance of HIV therapy.

Product Details

PGX-HIV StripAssay® ref4-710